Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B

Table 2 Sequential changes and comparisons of serum ferritin levels (μg/L) at different time points during lamivudine treatment in HBeAg-negative and -positive groups at end of treatment

Group	Baseline	Months after treatment
		3	6	12
HBV DNA ( - ) group (n = 12)	250.16 ± 190.78	135.72 ± 138.33	106.13 ± 74.10	97.80 ± 76.96
HBV DNA ( + ) group (n = 26)	190.45 ± 123.50	166.05 ± 96.51	35.31 ± 71.60	140.18 ± 87.40
P values	0.336	0.439	0.262	0.160